🇯🇵 Xocova in Japan

PMDA authorised Xocova on 22 November 2022

Marketing authorisations

PMDA — authorised 22 November 2022

  • Marketing authorisation holder: Shionogi & Co., Ltd.
  • Status: approved

Xocova in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in Japan

Frequently asked questions

Is Xocova approved in Japan?

Yes. PMDA authorised it on 22 November 2022; PMDA has authorised it.

Who is the marketing authorisation holder for Xocova in Japan?

Shionogi & Co., Ltd. holds the Japanese marketing authorisation.